Invesaro

Stocks FCX Financial statements

Financial statements

FREEPORT-MCMORAN INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data FREEPORT-MCMORAN INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2023FY2025
Revenue14,83016,40318,94514,40214,19822,84523,27122,85525,45525,915
Cost of revenue17,53411,98013,46613,12511,65514,03015,08915,69517,79518,618
Gross profit-2,7044,4235,4791,2772,5438,8158,1827,1607,6607,297
Selling, general and administrative597477422394370383420479513545
Operating income-2,7293,6904,7541,0912,4378,3667,0376,2256,8646,518
Other non-operating income494976-13859-105207286362223
Pre-tax income-3,4722,9023,8923061,7977,6596,7156,0066,9076,372
Income tax3718839915109442,2992,2672,2702,5232,221
Income from continuing operations-3,9011,7512,613-2455964,299
Net income to minority interests-290278292-502661,0591,0111,9032,5101,948
Net income-4,1541,8172,602-2395994,3063,4681,8481,8892,204
EBITDA-1195,4046,5082,5033,96510,3649,0568,2939,1058,762
EPS, basic-3.161.251.79-0.170.412.93
EPS, diluted-3.161.251.78-0.170.412.90
Shares, basic (weighted)1,3181,4471,4491,4511,4531,4661,4411,4341,4381,437
Shares, diluted (weighted)1,3181,4541,4581,4511,4611,4821,4511,4431,4451,443
Dividend per share0.000.000.200.200.000.380.600.600.600.60

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2023FY2025
Cash and equivalents4,2454,5264,2172,0203,6578,0688,1464,7583,9233,824
Receivables1,1261,3228297418921,1681,3361,209578977
Other current assets199286422655341523381375535580
Total current assets10,43510,62610,4647,9159,30314,83015,61314,06513,29613,790
Property, plant and equipment23,21922,99428,01029,58429,81830,34532,62735,29538,51440,736
Lease right-of-use assets2322073373424488531,205
Intangible assets305307398402401412416422428432
Long-term investments70747984102125
Other non-current assets1,9562,2732,1721,8851,5601,4601,6011,8101,5071,658
Total assets37,31737,30242,21640,80942,14448,02251,09352,50654,84858,167
Accounts payable1,5401,5461,6611,6541,4732,0352,7012,4662,7892,948
Deferred revenue829135
Short-term debt1,2321,414175343721,03776641466
Total current liabilities4,2654,9143,3293,2093,4175,8926,3455,8155,4966,019
Long-term debt14,79511,81511,1249,8219,6779,0789,5838,6568,9078,913
Lease liabilities02041902812943476921,010
Other non-current liabilities1,7452,0122,2302,4912,2691,6831,5621,6481,1951,296
Total liabilities28,06026,00624,32423,36123,47625,00326,22225,19626,07027,401
Total debt2,22811,81511,1419,8269,7119,45010,6209,4228,9489,379
Paid-in capital26,69026,75126,01325,83026,03725,87525,32224,63723,79723,680
Retained earnings-16,540-14,722-12,041-12,280-11,681-7,375-3,907-2,059-1701,385
Treasury stock-3,708-3,723-3,727-3,734-3,758-4,292-5,701-5,773-5,894-6,024
Other comprehensive income-548-487-605-676-583-388-320-274-314-305
Shareholders' equity6,0517,9779,7989,29810,17413,98015,55516,69317,58118,899
Minority interests3,2063,3198,0948,1508,4949,0399,31610,61711,19711,867
Total equity9,25711,29617,89217,44818,66823,01924,87127,31028,77830,766
Total liabilities and equity37,31737,30242,21640,80942,14448,02251,09352,50654,84858,167

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2023FY2025
Net income-4,0252,0952,894-1898655,3654,4793,7514,3994,152
Depreciation and amortization2,6101,7141,7541,4121,5281,9982,0192,0682,2412,244
Stock-based compensation86717663999895109109121
Deferred income tax273-16321645298211299373-74253
Change in receivables-175427649119132-47256166460-521
Change in inventory117-169-53725942-618-573-873-638-709
Change in payables-28110-106-60115487-73-161143802
Cash from operations3,7374,6663,8631,4823,0177,7155,1395,2797,1605,610
Capital expenditures-2,813-1,410-1,971-2,652-1,961-2,115-3,469-4,824-4,808-4,494
Cash from investing3,553-1,321-5,018-2,103-1,264-1,964-3,440-4,956-5,028-4,472
Debt issued3,6819556321,8793,5311,2015,7351,7812,2513,195
Debt repaid-7,625-3,812-2,717-3,197-3,724-1,461-4,515-2,980-2,731-2,777
Stock issued1,51503,500251210125472912
Share buybacks00-488-1,3470-59-107
Dividends paid-6-2-218-291-73-331-866-863-865-865
Cash from financing-3,166-3,055900-1,556-128-1,340-1,623-2,650-3,284-1,876
Net change in cash4,124290-255-2,1771,6254,41176-2,327-1,152-738
Free cash flow9243,2561,892-1,1701,0565,6001,6704552,3521,116
Interest paid743565500591472640417419206256
Income taxes paid2037022,0006103971,3003,1002,0072,5522,898

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $72.31 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin27.1%Gross profit / revenue.
Operating margin26.7%Operating income / revenue.
EBITDA margin35.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin25.7%Pre-tax income / revenue.
Net margin11.4%Net income / revenue.
Operating cash flow margin22.8%Cash from operations / revenue.
Effective tax rate31.1%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)14.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)4.9%Net income / average total assets.
Return on invested capital (ROIC)18.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue2.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.6%Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue8.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y1.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y3.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y12.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-4.7%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-3.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y23.5%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-5.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-2.5%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y21.7%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-3.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-1.1%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y17.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y16.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-14.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y29.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-21.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y3.0%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y13.2%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-52.6%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-12.6%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y1.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y0.0%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y7.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y6.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y13.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y6.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y4.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y6.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.07xCurrent assets / current liabilities.
Quick ratio0.70x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.60x(Cash + short-term investments) / current liabilities.
Debt / equity0.47xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets15.7%Total debt / total assets.
Liabilities / assets46.1%Total liabilities / total assets.
Net debt$5.31BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.59xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$7.31BCurrent assets - current liabilities.
Tangible book value$20.11BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.43xRevenue / average total assets.
Fixed asset turnover0.62xRevenue / average property, plant and equipment.
Receivables turnover36.2xRevenue / average receivables.
Days sales outstanding10 days365 x average receivables / revenue.
Days payables89 days365 x average accounts payable / cost of revenue.

Per share

MetricValueHow it is calculated
EPS, diluted$2.04Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$17.94Revenue / diluted weighted shares.
Operating cash flow per share$4.09Cash from operations / diluted weighted shares.
Book value per share$13.94Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$13.94Tangible book value / shares outstanding.
Cash per share$2.83(Cash + short-term investments) / shares outstanding.
Payout ratio29.4%Dividends paid / net income, when net income is positive.

Valuation

MetricValueHow it is calculated
Market cap$103.84BShare price x shares outstanding.
Enterprise value$109.14BMarket cap + total debt - cash - short-term investments.
P/E35.3xMarket cap / net income. Only when net income is positive.
P/S4.01xMarket cap / revenue.
P/B5.16xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book5.16xMarket cap / tangible book value, when positive.
P/OCF17.6xMarket cap / cash from operations, when positive.
EV/Sales4.22xEnterprise value / revenue.
EV/EBIT15.8xEnterprise value / operating income, when both are positive.
EV/EBITDA12.0xEnterprise value / EBITDA, when both are positive.
Earnings yield2.8%Net income / market cap (the inverse of P/E).
Dividend yield0.8%Dividends paid over the period / market cap.
Shareholder yield1.0%(Dividends paid + share buybacks) / market cap.
What was FREEPORT-MCMORAN INC's revenue in fiscal 2025?

FREEPORT-MCMORAN INC reported revenue of $25.92B for fiscal 2025, 1.8% higher than the year before.

Was FREEPORT-MCMORAN INC profitable in fiscal 2025?

Yes. Net income was $2.20B, a net margin of 8.5%.

How much free cash flow did FREEPORT-MCMORAN INC generate in fiscal 2025?

Cash from operations of $5.61B minus capital expenditures of $4.49B left free cash flow of $1.12B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to FREEPORT-MCMORAN INC